Brian J. Day, PhD

Brian J. Day
Brian J. Day, PhD, is a Professor at National Jewish Health. Dr. Day serves as the Vice President of Research and Director of the Office of Research Innovation at National Jewish Health.
Vice President of Research
Director, Office of Research Innovation
Department of Medicine
Research AreasResearch Areas

Special Interests

Research Interests

Cystic Fibrosis, COPD, chronic beryllium disease, interstitial lung disease, sulfur mustard lung injury, drug development. Adaptive glutathione responses to cigarette smoke in COPD. (NIH RO1 HL084469-05) (Primary Investigator). Novel Antioxidant Therapeutics for Sulfur Mustard Toxicity. (NIH U54 ES015678-06) (Project 2 Leader). Modulation of lung inflammation by CFTR-dependent thiols. (Cystic Fibrosis Foundation Research Grant) (Primary Investigator). Targeting oxidative stress in chronic beryllium disease.(NIH RO1 ES017582-04) (Multiple Primary Investigator).


Purdue University (W Lafayette, IN), PhD, Pharmacology and Toxicology
University of Montana (Missoula, MT), BS with Honors, School of Pharmacy
Duke University (Durham, NC), Post-doctoral Integrated Toxicology & Pulmonary Fellow

Awards & Recognition

Vice President of Research, Director of the Office of Research Innovation
Chief Science Officer, Aeolus Pharmaceuticals
Chairman, Board of Publications Committee, Mechanisms Specialty Section Councilor, Society of Toxicology
NIH Study Section Member, LIRR

Professional Memberships

Society of Toxicology
American Thoracic Society
Society of Free Radical Biology and Medicine
American Heart Association
American Chemical Society


Day BJ, Min E, Huang J, Stanley C. The Use of Thiocyanate Formulations to Create Manganese Porphyrin Antioxidants That Supplement Innate Immunity. Antioxidants (Basel). 2022 Jun 25;11(7):1252. doi: 10.3390/antiox11071252. PMID: 35883743; PMCID: PMC9311894.

Schaunaman N, Crue T, Cervantes D, Schweitzer K, Robbins H, Day BJ, Numata M, Petrache I, Chu HW. Electronic cigarette vapor exposure exaggerates the pro-inflammatory response during influenza A viral infection in human distal airway epithelium. Arch Toxicol. 2022 Aug;96(8):2319-2328. doi: 10.1007/s00204-022-03305-2. Epub 2022 Jun 7. PMID: 35672461; PMCID: PMC9172985.

Academic Affiliations

Professor of Medicine, Pharmaceutical Sciences and Immunology, University of Colorado Denver
Professor, Colorado School of Public Health, University of Colorado Denver

Website Information

Day Lab

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 877.225.5654

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.